Table 1.
Baseline and follow-up characteristics of individuals initiated on CGM in the first month of diabetes diagnosis (n = 41)
| Age at onset, years | 9.7 ± 4.1 |
| Sex | |
| Male | 23 (56) |
| Female | 18 (44) |
| Insurance type | |
| Public | 4 (10) |
| Private | 37 (90) |
| Race | |
| Non-Hispanic white | 17 (41) |
| Hispanic | 4 (10) |
| Asian and Pacific Islander | 5 (12) |
| Alaskan Native or American Native | 0 (0) |
| Other | 5 (12) |
| Unknown | 10 (24) |
| Primary language | |
| English | 38 (93) |
| Spanish | 2 (5) |
| Other | 1 (2) |
| Diabetic ketoacidosis at onset | 20 (49) |
| Outpatient education | 20 (49) |
| Education at Stanford | 37 (90) |
| HbA1c at onset, % (mmol/mol) | 12.2 ± 1.8 (110) |
| Days to CGM start | 9.0 ± 8.8 |
| Days to most recent visit | 94.1 + 64.3 |
| Continuing to use CGM | 38 (93) |
| Days worn over the last 2 weeks (n = 27)* | 13.2 + 2.3 |
| Mean HbA1c, % (mmol/mol) (n = 32)† | 7.2 + 1.0 (55) |
| TIR, % (n = 38) | 69.6 + 18.9 |
| Time in hypoglycemia, % (n = 38) | 3.4 + 3.9 |
| Time in hyperglycemia, % (n = 38) | 26.7 + 18.9 |
Data are n (%) or mean ± SD.
*
Data were based only on patients with a scanned report in the medical record or with the data available in the Clarity portal.
†
Most recent visit for six youth was within the first month of diagnosis.